Investigation on the stability of saquinavir loaded liposomes: Implication on stealth, release characteristics and cytotoxicity

International Journal of Pharmaceutics

Volumn 431, Issue 1-2, 2012, Pages 120-129

  Ramana, Lakshmi Narashimhan ^a   Sharma, Shilpee ^b   Sethuraman, Swaminathan ^a   Ranga, Udaykumar ^b   Krishnan, Uma Maheswari ^a  

^a SASTRA UNIVERSITY   (India)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

Non PEGylated liposomes; PEGylated liposomes; Saquinavir

Indexed keywords

LIPOSOME; MACROGOL; SAQUINAVIR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULARY; DRUG STABILITY; ENCAPSULATION; FLOW CYTOMETRY; LEUKEMIA CELL LINE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

CALORIMETRY, DIFFERENTIAL SCANNING; CELL SURVIVAL; DRUG STABILITY; HIV PROTEASE INHIBITORS; HUMANS; JURKAT CELLS; KINETICS; LIPOSOMES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SAQUINAVIR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84861333908     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.04.054     Document Type: Article

References (36)

1. M.M. Amiji, T.K. Vyas, and L.K. Shah Role of nanotechnology in HIV/AIDS treatment potential to overcome the viral reservoir challenge Discov. Med. 6 2006 157 162
2. S. Anuradha, S. Sethuraman, and U.M. Krishnan Fabrication of uniaxially aligned 3D electrospun scaffolds for neural regeneration Biomed. Mater. 6 2011 1 10
3. F. Ashan, I.P. Rivas, M.A. Khan, and A.I. Torres Targetting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages J. Control. Release 79 2002 29 40
4. P. Covreur, and C. Vautheir Nanotechnology: intelligent design to treat complex disease Pharm. Res. 23 2006 1417 1450
5. T. Dutta, and N.K. Jain Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer Biochim. Biophys. Acta 1770 2007 681 686
6. T. Dutta, H.B. Agashe, M. Garg, P. Balasubramanium, M. Kabra, and N.K. Jain Poly(propyleneimine) dendrimer based nanocontainers for targeting of efavirenz, to human monocyte/macrophages in vitro J. Drug Target. 15 2007 89 98
7. G.M.M. ElMaghraby, A.C. Williams, and B.W. Barry Drug interaction and location in liposomes: correlation with polar surface areas Int. J. Pharm. 292 2005 179 185
8. S. Fauci Anthony The human immunodeficiency virus: infectivity and mechanisms of pathogenesis Science 239 1988 617 622
9. B. Gabriele, and C. Gregor Molecular mechanism of the lipid vesicle longevity in vivo Biochim. Biophys. Acta 1146 1993 157 168
10. U. Gupta, H.B. Agashe, A. Asthana, and N.K. Jain Dendrimers: novel polymeric nano architecture for solubility enhancement Biomacromolecules 7 2006 649 658
11. H.D. Hee, S.C. Byung, and C.S. Ho Doxorubicin encapsulated thermosensitive liposome modified with poly (N-Isopropylacrylamide-co- acrylamide): drug release behavior and stability in presence of serum Eur. J. Pharm. Biopharm. 62 2006 110 116
12. H. Heiati, R. Tawashi, and N.C. Philips Solid lipid nanoparticles as drug carriers II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic drug 3′-azido-3′- deoxythymidine palmitate in mice Int. J. Pharm. 351 2008 271 281
13. M. Howard Temin Mechanisms of cell killing/Cytopathic effects by nonhuman retroviruses Rev. Infect. Dis. 10 1988 399 405
14. S. Jagannathan, M.R. Berlyn, and M. Samir An experimental and theoretical analysis of ultrasound induced permeabilization of cell membranes Biophys. J. 85 2003 3087 3101
15. L. Jubo, L. Helen, H. Mario, Y. Aiping, and A. Chrisine Liposome formulation of a novel hydrophobic aryl imidazole for anticancer therapy Cancer Chemother. Pharmacol. 58 2006 306 318
16. G. Jie, Z. Wei, H. Jinqui, L. Huimei, Z. He, Z. Guichen, L. Bohua, L. Ying, Z. Hao, K. Geng, Z. Dapeng, W. Hao, G. Yajun, and Z. Yanqiang Tumor targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes Int. J. Pharm. 374 2009 145 152
17. H. Kaname, T. Hiroyuki, S. Hideki, S.S. Masahiko, S. Yoshihiro, and O. Naotake Carboxyfluorescein lekage from poly(ethylene glycol) grafted liposomes induced by the interaction with serum Chem. Pharm. Bull. 54 2006 80 84
18. J.A. Karlowsky, and G.G. Zhanel Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides Clin. Infect. Dis. 15 1992 654 667
19. A. Katragadda, R. Bridgman, and G. Betagiri Effect of liposome composition and cholesterol on the cellular uptake of stavudine by human monocyte/macrophages Cell. Mol. Biol. Lett. 5 2000 483 493
20. Y.C. Kuo, and F.L. Su Transport of stavudine, delavirdine, and saquinavir across the blood brain barrier by polybutylcyanoacrylate methy methacrylate sulfopropyl methacrylate and solid lipid nanoparticles Int. J. Pharm. 340 2007 143 152
21. R.N. Lakshmi, S. Swaminathan, R. Udaykumar, and K. Uma maheswari Developmental of a liposomal nanodelivery system for nevirapine J. Biomed. Sci. 17 2010 57 65
22. X. Li, and W.K. Chan Transport, metabolism and elimination mechanism of anti HIV agents Adv. Drug Deliv. Rev. 39 1999 81 103
23. P. Lockman, R. Mumper, M. Khan, and D. Allen Nanoparticle technology for drug delivery across the blood-brain barrier Drug Dev. Ind. Pharm. 28 2002 1 13
24. J.M. Lanao, E. Briones, and C.I. Colino Recent advances in delivery system for anti-HIV-1 therapy J. Drug Target. 15 2007 21 36
25. V. Margherita, C. Donato, C. Christian, P. Donatella, C. Marilena, R. Diego, and F. Massimo Evaluation of the activity of Gemicitabine loaded PEGylated unilamellar liposome against papillary thyroid cancer cells Open Drug Delivery J. 4 2010 55 62
26. N. Okada, T. Yasuda, T. Sumita, and H. Okada Activation of the alternate complement pathway of guinea pig by liposomes incorporated with trinitrophenylated phosphatidylethanolamine Immunology 45 1982 115 124
27. M. Paola, M. Francesca, L. Maria, R. Gonzalez, M. Ilaria, G. Carla, and M.R. Antonio Development characterization and in vivo evaluation of benzocaine loaded liposomes Eur. J. Pharm. Biopharm. 67 2007 86 95
28. J. Sabin, G. Prieto, J.M. Ruso, R. Hidalgo-Alvarez, and F. Sarmiento Size and stability of liposomes: a possible role of hydration and osmotic forces Eur. Phys. J. E 20 2006 401 408
29. O. Tirosh, Y. Barenholz, J. Katzhelender, and A. Priev Hydration of polyethylene glycol-grafted liposomes Biophys. J. 74 1998 1371 1379
30. E.J. Tove, A.N. Esben, R. Sibylla, B. Martin, and L.F. Sigrid Distearoylphosphatidyl ethanolamine based liposome for ultrasound mediated drug delivery Eur. J. Pharm. Biopharm. 47 2010 327 333
31. E.J. Tove, A.N. Esben, B. Sabine, S. Rolf, B. Martin, and L.F. Sigrid Ultrasound-mediated destabilization and drug release from liposome comprising Dioleoylphosphatidylethanolamine Eur. J. Pharm. Biopharm. 42 2010 380 386
32. G. Umesh, and K. Narendra jain Non- polymeric nano-carriers in HIV/AIDS drug delivery and targeting Adv. Drug Deliv. Rev. 62 2010 478 490
33. A.I. Vitas, R. Diaz, and C. Gamazo Effect of composition and method of preparation of liposome on their stability and interaction with murine monocyte infected with Brucella abortus Antimicrob. Agents Chemother. 40 1996 146 151
34. M. Vono, D. Cosco, C. Celia, D. Paolino, M. Celano, D. Russo, and M. Fresta In vitro evaluation of the activity of gemcitabine loaded PEGylated unilamellar liposomes against papillary thyroid cancer cells Open Drug Delivery J. 4 2010 55 62
35. H. Yan-le, D. Ying-jie, C. Yan, W. Xiu Man, Z. Hai-Jun, and S. Xu- Bin In vitro and in vivo studies of different liposomes containing Topotecan Arch. Pharm. Res. 28 2005 626 635
36. T. Yang, C. Fu-de, C. Min- koo, C. Jei-Won, C. Suk-jae, S. Chang-Koo, and K. Dae-Duk Enhanced solubility and stability of PEGylated liposomal palcitaxel: in vitro and in vivo evaluation Int. J. Pharm. 338 2007 316 326